These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 15241728)
1. The role of progesterone metabolism and androgen synthesis in renal blood pressure regulation. Quinkler M; Diederich S; Bähr V; Oelkers W Horm Metab Res; 2004 Jun; 36(6):381-6. PubMed ID: 15241728 [TBL] [Abstract][Full Text] [Related]
2. Cortisol, 11beta-hydroxysteroid dehydrogenases, and hypertension. van Uum SH; Lenders JW; Hermus AR Semin Vasc Med; 2004 May; 4(2):121-8. PubMed ID: 15478032 [TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study. Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592 [TBL] [Abstract][Full Text] [Related]
4. Progesterone metabolism in the human kidney and inhibition of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites. Quinkler M; Johanssen S; Grossmann C; Bähr V; Müller M; Oelkers W; Diederich S J Clin Endocrinol Metab; 1999 Nov; 84(11):4165-71. PubMed ID: 10566667 [TBL] [Abstract][Full Text] [Related]
5. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function. Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836 [TBL] [Abstract][Full Text] [Related]
6. Adrenal gland involvement in the regulation of renal 11beta-hydroxysteroid dehydrogenase 2. Zallocchi ML; Matkovic L; Calvo JC; Damasco MC J Cell Biochem; 2004 Jun; 92(3):591-602. PubMed ID: 15156570 [TBL] [Abstract][Full Text] [Related]
7. Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues. Sharma KK; Lindqvist A; Zhou XJ; Auchus RJ; Penning TM; Andersson S Mol Cell Endocrinol; 2006 Mar; 248(1-2):79-86. PubMed ID: 16337083 [TBL] [Abstract][Full Text] [Related]
8. Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD). Mongia A; Vecker R; George M; Pandey A; Tawadrous H; Schoeneman M; Muneyyirci-Delale O; Nacharaju V; Ten S; Bhangoo A J Clin Endocrinol Metab; 2012 Oct; 97(10):3622-9. PubMed ID: 22872687 [TBL] [Abstract][Full Text] [Related]
9. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin. Latif SA; Pardo HA; Hardy MP; Morris DJ Mol Cell Endocrinol; 2005 Nov; 243(1-2):43-50. PubMed ID: 16188377 [TBL] [Abstract][Full Text] [Related]
10. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. Draper N; Stewart PM J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenases. Diederich S; Scholz T; Eigendorff E; Bumke-Vogt Ch; Quinkler M; Exner P; Pfeiffer AF; Oelkers W; Bähr V Horm Metab Res; 2004 Jun; 36(6):423-9. PubMed ID: 15241735 [TBL] [Abstract][Full Text] [Related]
12. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men. Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221 [TBL] [Abstract][Full Text] [Related]
13. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues revisited. Morris DJ; Latif SA; Brem AS Steroids; 2009 Jan; 74(1):1-6. PubMed ID: 19013186 [TBL] [Abstract][Full Text] [Related]
14. 11β-HSD2 SUMOylation Modulates Cortisol-Induced Mineralocorticoid Receptor Nuclear Translocation Independently of Effects on Transactivation. Jiménez-Canino R; Lorenzo-Díaz F; Odermatt A; Bailey MA; Livingstone DEW; Jaisser F; Farman N; Alvarez de la Rosa D Endocrinology; 2017 Nov; 158(11):4047-4063. PubMed ID: 28938454 [TBL] [Abstract][Full Text] [Related]
15. Extracellular ATP determines 11beta-hydroxysteroid dehydrogenase type 2 activity via purinergic receptors. Kadereit B; Fustier P; Shojaati K; Frey BM; Frey FJ; Mohaupt MG J Am Soc Nephrol; 2005 Dec; 16(12):3507-16. PubMed ID: 16251242 [TBL] [Abstract][Full Text] [Related]
16. 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension. Glorioso N; Filigheddu F; Parpaglia PP; Soro A; Troffa C; Argiolas G; Mulatero P Eur Heart J; 2005 Mar; 26(5):498-504. PubMed ID: 15618035 [TBL] [Abstract][Full Text] [Related]
17. Human renal 11beta-hydroxysteroid dehydrogenase 1 functions and co-localizes with COX-2. Gong R; Morris DJ; Brem AS Life Sci; 2008 Mar; 82(11-12):631-7. PubMed ID: 18261751 [TBL] [Abstract][Full Text] [Related]
18. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess. Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated. Ge RS; Dong Q; Sottas CM; Latif SA; Morris DJ; Hardy MP Mol Cell Endocrinol; 2005 Nov; 243(1-2):35-42. PubMed ID: 16188378 [TBL] [Abstract][Full Text] [Related]
20. Localisation of 11β-Hydroxysteroid Dehydrogenase Type 2 in Mineralocorticoid Receptor Expressing Magnocellular Neurosecretory Neurones of the Rat Supraoptic and Paraventricular Nuclei. Haque M; Wilson R; Sharma K; Mills NJ; Teruyama R J Neuroendocrinol; 2015 Nov; 27(11):835-49. PubMed ID: 26403275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]